ICLR

ICON PLC ICLR

NasdaqLarge CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #1,592 of 2,925

Why it scores 51Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$2.06B

Quarter to Jun 30

Net income

$72.58M

Quarter to Jun 30

Free cash flow

$238.85M

Quarter to Jun 30

Operating margin

6.7%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$13.86B total
Artisan Partners Limited Partnership
$1.50B+4.3%
WELLINGTON MANAGEMENT GROUP LLP
$924.15M-10.0%
FMR LLC
$915.68M+26.3%
Invesco Ltd.
$914.45M+35.7%
HARRIS ASSOCIATES L P
$776.16M+2.7%
Brave Warrior Advisors, LLC
$547.76M+5.2%
GREENHAVEN ASSOCIATES INC
$538.61M+54.8%
PRINCIPAL FINANCIAL GROUP INC
$512.61M-10.9%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
$369.45M-22.8%
Ruane, Cunniff & Goldfarb L.P.
$355.77M+25.3%
Boston Partners
$281.40M+94.1%
Trinity Street Asset Management LLP
$266.73M+27.1%
D. E. Shaw & Co., Inc.
$235.75M+13.2%
DIMENSIONAL FUND ADVISORS LP
$220.65M+61.0%
EARNEST PARTNERS LLC
$215.86M+40.3%
Maple Rock Capital Partners Inc.
$208.38M+257.8%
1832 Asset Management L.P.
$207.56M+0.1%
BRANDES INVESTMENT PARTNERS, LP
$205.98M-17.4%
Capital World Investors
$192.13M+0.1%
AMERIPRISE FINANCIAL INC
$170.17M+858.2%
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.
$167.05M+4.7%
SEI INVESTMENTS CO
$156.72M+19.1%
EQUITY INVESTMENT CORP
$154.41M-18.9%
LYRICAL ASSET MANAGEMENT LP
$153.07M-6.1%
ALLIANCEBERNSTEIN L.P.
$152.51M+2.5%
See all 426 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ICLR

Earnings Per Share

13fpro.ai/company/ICLR

Loading ratio trend…

ICLR key financials by period

Reported revenue, net income and operating margin by fiscal year, from ICON PLC's annual filings on SEC EDGAR.

ICON PLC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$8.3B$229.3M5.4%
FY 2024$8.2B$739.1M12.6%
FY 2023$8.1B$554.2M11.2%
FY 2022$7.7B$505.3M10.3%
FY 2021$5.5B$153.2M6.9%
FY 2020$2.8B$332.3M14.0%
Source: ICLR filings on SEC EDGAR →

Companies similar to ICLR

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

ICLR insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in ICLR

6 transactions in ICLR reported by 3 members of Congress under the STOCK Act, most recent trade Aug 14, 2026. Reported transactions, not recommendations.

All Congress stock trades →

About ICON PLC (ICLR): stock profile, AI score and financials

ICON PLC (ICLR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ICLR at 50.7/100 on a composite quality score built from its SEC filings, placing it at rank #1,592 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), ICON PLC reports quarterly revenue of $2.1B, net income of $72.6M, an operating margin of 6.7%. Top institutional holders of ICLR by reported 13-F value include Artisan Partners Limited Partnership, WELLINGTON MANAGEMENT GROUP LLP, FMR, based on the most recent SEC filings. ICLR trades on the Nasdaq exchange and files with the SEC under CIK 1060955. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ICLR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ICON PLC directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1060955 →